501
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999–2009

, , &
Pages 346-352 | Received 05 Feb 2013, Accepted 17 Mar 2013, Published online: 29 Apr 2013

References

  • Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry. 1970;33:338–57.
  • National Institute for Health and Clinical Excellence. Riluzole (Rilutek) for the treatment of Motor Neurone Disease. Technology appraisal TA20. London: NICE; January 2001.
  • Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998;160 (Suppl 1):S6–24.
  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
  • Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925–1998. Neurology. 2002;59:280–2.
  • Piemonte, Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001; 56:239–44.
  • Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68: 141–5.
  • Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979–2001. Neuroepidemiology. 2005;25:144–52.
  • Marin B, Gil J, Preux PM, Funalot B, Couratier P. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007. Amyotroph Lateral Scler. 2009;10: 216–20.
  • Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
  • Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991–2005. Arch Neurol. 2009;66:515–9.
  • Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population based study. Neurology. 2009;72: 725–31.
  • Gordon PH, Mehal JM, Holman RC, Rowland LP, Rowland AS, Cheek JE. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska Natives. JAMA Neurol. 2013;70:476–80.
  • Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population based study. Eur J Neurol. 2009; 16:745–51.
  • Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsh G, et al. Rising mortality from motor neuron disease in the USA, 1962–84. Lancet. 1989;1:710–3.
  • World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Geneva: World Health Organization 1992.
  • World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Based on Recommendations of the Ninth Revision Conference, 1975. Geneva: World Health Organization 1977.
  • U.S. Department of Health and Human Services: vital statistics mortality data, multiple cause detail, 1999–2009. Public use data tape contents and documentation package. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; 2012.
  • U.S. Bureau of the Census. Intercensal Estimates of the Population by Age, Sex, and Race: 2000–2009. Washington, DC: US Bureau of the Census 2012.
  • U.S. Bureau of the Census. Intercensal Estimates of the Population by Age, Sex, and Race: 1999. Washington, DC: US Bureau of the Census 2002.
  • Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People Statistical Notes, no. 20. National Center for Health Statistics, Hyattsville, MD; 2001.
  • Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods. 3rd edn. Pacific Grove, CA: Duxbury Press; 1998.
  • Lehmann E. Non-parametrics: Statistical Methods Based on Ranks. New York, NY: Wiley; 1975.
  • Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968–1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241:448–55.
  • Govoni V, Granieri E, Capone J, Manconi M, Casetta I. Incidence of amyotrophic lateral sclerosis in the local health district of Ferrara, Italy, 1964–1998. Neuroepidemiology. 2003;22:229–34.
  • Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta. 2006;1762:1150–7.
  • Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980;30:453–62.
  • Gordon PH, Artaud F, Aouba A, Laurent F, Meininger V, Elbaz A. Changing mortality for motor neuron disease in France (1968–2007): an age-period-cohort analysis. Eur J Epidemiol. 2011;26:729–37.
  • Forbes RB, Colville S, Swingler RJ, Scottish ALSMNDR. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or over. Age Ageing. 2004;33:131–4.
  • Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68: 1002–7.
  • Zou ZY, Wang XN, Liu MS, Sun Q, Li XG, Cui LY, et al. Identification of a novel missense mutation in angiogenin in a Chinese amyotrophic lateral sclerosis cohort. Amyotroph Lateral Scler. 2012;13:270–5.
  • Benedet AL, Moraes CF, Camargos EF, Oliveira LF, Souza VC, Lins TC, et al. Amerindian genetic ancestry protects against Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;33:311–7.
  • Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640–5.
  • Alonso V, Villaverde-Hueso A, Hens MJ, Morales-Piga A, Abaitua I, de la Paz MP. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990–2005). Amyotroph Lateral Scler. 2011;12:192–8.
  • Pradas J, Puig T, Rojas-Garcia R, Viguera ML, Gich I, Logroscino G. Amyotrophic lateral sclerosis in Catalonia: a population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2013; Early Online: 16.
  • Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094–8.
  • Ragonese P, Cellura E, Aridon P, D’Amelio M, Spataro R, Taiello AC, et al. Incidence of amyotrophic lateral sclerosis in Sicily: a population based study. Amyotroph Lateral Scler. 2012;13:284–7.
  • Groman R, Ginsburg J, American College of Physicians Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med. 2004;141:226–32.
  • Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Project. Amyotroph Lateral Scler. 2012;13: 69–73.
  • Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992;46:517–8.
  • Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925–1977. Neurology. 1980;30: 463–70.
  • Yeo L, Lynch C, Hardiman O. Validating population based registers for ALS: how accurate is death certification?J Neurol. 2010;257:1235–9.
  • Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health. 2012;75:28–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.